Document is current
Any future updates will be listed below
-
Authors
Postill, Gemma https://orcid.org/0000-0001-6185-995X
Im, James H. B. https://orcid.org/0000-0002-9718-0284
Tang, Furong https://orcid.org/0000-0002-1688-3413
Benchimol, Eric I. https://orcid.org/0000-0002-3984-8426
Kuenzig, M. Ellen https://orcid.org/0000-0001-8855-3598
-
Funding
Funding for this research was provided by:
Comprehensive Research Experience for Medical Students (CREMS) Summer Research Program at the University of Toronto
Northbridge Financial Corporation Chair in Inflammatory Bowel Diseases
- License Information
-
More Information
Article History
Received: 25 February 2025
Accepted: 22 March 2025
First Online: 2 April 2025
Declarations
:
: EIB has acted as a consultant for the Dairy Farmers of Ontario and McKesson Canada for matters unrelated to medications used to treat inflammatory bowel disease. He has also acted as a consultant for the Canadian Drug Agency. All other authors have no known conflicts of interest.
: The data used are publicly available (published by Statistics Canada). All data were de-identified, and vetting procedures were applied to ensure confidentiality and protection of the respondents prior to publication of the data. Additional institution-specific ethical approval was not required.
: Not applicable.
